By expenditures
| Name | Title | Type |
|---|---|---|
| Chris Terhark | AUDIT MANAGING DIRECTOR | Auditee |
| Adam Voigts | CHIEF FINANCIAL OFFICER | Auditee |
| Chad Lassen CPA | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 326226 | 2024 | 2024-10-28 | Cliftonlarsonallen LLP | $66.86M |
| 2147 | 2023 | 2023-11-02 | Cliftonlarsonallen LLP | $67.63M |
| 49150 | 2022 | 2022-11-28 | Deloitte & Touche LLP | $67.19M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 326226 | 2024 | 2024-10-28 | 1080397 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 1080396 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 1080395 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 1080394 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 1080393 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 1080392 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 1080391 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 503955 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 503954 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 503953 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 503952 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 503951 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 503950 | 2024-001 | Significant Deficiency | - | N |
| 326226 | 2024 | 2024-10-28 | 503949 | 2024-001 | Significant Deficiency | - | N |
| 2147 | 2023 | 2023-11-02 | 577567 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 577566 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 577565 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 577564 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 577563 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 577562 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 577561 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 577560 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 1125 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 1124 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 1123 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 1122 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 1121 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 1120 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 1119 | 2023-001 | Significant Deficiency | - | L |
| 2147 | 2023 | 2023-11-02 | 1118 | 2023-001 | Significant Deficiency | - | L |